Cases & Deals

  • Home
  • Practices
  • Huadong Medicine announces strategic collaboration with PulseCath to develop and commercialize the iVAC mechanical circulatory product in Greater China

Share

Huadong Medicine announces strategic collaboration with PulseCath to develop and commercialize the iVAC mechanical circulatory product in Greater China

September 2021

Client(s) Huadong Medicine Co. Ltd.

Jones Day represented Huadong Medicine Co. Ltd. in an exclusive license and collaboration agreement with PulseCath B.V. to develop and commercialize iVAC technology in Greater China and selected other Asian Pacific countries.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.